Abstract
Hematopoietic stem cell transplantation (HSCT) is an integral part of the treatment of many patients with acute myeloid leukemia (AML). Despite extensive study, the appropriate role and timing of allogeneic and autologous transplantation in AML are poorly defined. This review critically analyzes the extensive literature, focusing on the recent advances, and provides practical recommendations for the use of HSCT in AML.
Original language | English (US) |
---|---|
Pages (from-to) | 556-567 |
Number of pages | 12 |
Journal | Biology of Blood and Marrow Transplantation |
Volume | 14 |
Issue number | 5 |
DOIs | |
State | Published - May 2008 |
Externally published | Yes |
Keywords
- Acute leukemia
- Acute myeloid leukemia
- Bone marrow transplantation
- Graft-versus-leukemia effect
- Hematopoietic stem cell transplantation
- Reduced intensity
ASJC Scopus subject areas
- Hematology
- Transplantation